Growing community of inventors

Markt Indersdorf, Germany

Igor Ivanov

Average Co-Inventor Count = 7.37

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 25

Igor IvanovArthur F Kluge (1 patent)Igor IvanovChase C Smith (1 patent)Igor IvanovAndreas Schoop (1 patent)Igor IvanovRebecca L Casaubon (1 patent)Igor IvanovStefan Hannus (1 patent)Igor IvanovKatja Wosikowski-Buters (1 patent)Igor IvanovJoachim Vogt (1 patent)Igor IvanovFranz Obermayr (1 patent)Igor IvanovJan Eickhoff (1 patent)Igor IvanovKerrin Hansen (1 patent)Igor IvanovPeter Amon (1 patent)Igor IvanovMarino Schuhmacher (1 patent)Igor IvanovLars Neumann (1 patent)Igor IvanovMatthias Borgmann (1 patent)Igor IvanovKrishan Murthi (1 patent)Igor IvanovAlexander Backes (1 patent)Igor IvanovChristoph Schaab (1 patent)Igor IvanovIgor Ivanov (2 patents)Arthur F KlugeArthur F Kluge (96 patents)Chase C SmithChase C Smith (22 patents)Andreas SchoopAndreas Schoop (16 patents)Rebecca L CasaubonRebecca L Casaubon (6 patents)Stefan HannusStefan Hannus (4 patents)Katja Wosikowski-ButersKatja Wosikowski-Buters (3 patents)Joachim VogtJoachim Vogt (2 patents)Franz ObermayrFranz Obermayr (1 patent)Jan EickhoffJan Eickhoff (1 patent)Kerrin HansenKerrin Hansen (1 patent)Peter AmonPeter Amon (1 patent)Marino SchuhmacherMarino Schuhmacher (1 patent)Lars NeumannLars Neumann (1 patent)Matthias BorgmannMatthias Borgmann (1 patent)Krishan MurthiKrishan Murthi (1 patent)Alexander BackesAlexander Backes (1 patent)Christoph SchaabChristoph Schaab (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Forma Therapeutics, Inc. (1 from 125 patents)

2. Agennix Ag (1 from 2 patents)


2 patents:

1. 8232283 - Raf inhibitors

2. 8048888 - Anti-proliferative combination therapy using certain platinum-based chemotherapeutic agents and EGFR inhibitors or pyrimidine analogues

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/9/2026
Loading…